Speech-Language Pathologists in Miami, FL Accepting Medicare
880 Speech-Language Pathologists found. Showing 121 - 140
 Michelle Mary Bretl, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1120 Nw 14th St Fl 5, Miami, FL 33136 Phone: 305-243-5757 |
Stephanie Guillen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14750 Sw 26th St Ste 209, Miami, FL 33185 Phone: 305-364-5533 |
 Carpe Diem Academy Corporation Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11025 Sw 84th St, Miami, FL 33173 Phone: 833-971-1230 Fax: 305-971-3095 |
Speech 101 Therapy Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15459 Sw 92nd St, Miami, FL 33196 Phone: 330-256-0533 Fax: 330-595-4727 |
Ms. Zaira Liz Henriquez, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4284 Sw 161st Pl, Miami, FL 33185 Phone: 786-208-2814 Fax: 305-228-6251 |
Dr. Jennifer Ochoa, ED.D. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2450 Sw 137th Ave Ste 221, Miami, FL 33175 Phone: 305-228-4731 |
Alexandra Rojas Nunez, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8746 Sw 114th Pl, Miami, FL 33173 Phone: 305-798-4628 |
Ms. Jolie M Cummings, M.S. CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2625 S.w. 3 Avenue, Miami, FL 33129 Phone: 305-854-3282 Fax: 305-854-3268 |
Mrs. Angelica Seda Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 888 Nw 27th Ave Ste 5, Miami, FL 33125 Phone: 786-431-1133 Fax: 786-431-1287 |
Sarah Madeleine Bartels Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6850 Sw 44th St Apt 104, Miami, FL 33155 Phone: 305-582-2373 |
Eunice Ikpe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13155 Sw 134th St, Miami, FL 33186 Phone: 786-702-4663 |
I & L Compensatory Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14331 Sw 120th St Ste 110, Miami, FL 33186 Phone: 305-315-6078 |
Emily Rodriguez Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14286 Sw 122nd Ct, Miami, FL 33186 Phone: 786-423-2423 |
Natalia S Gonzalez Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1441 Sw 1st St, Miami, FL 33135 Phone: 787-247-4344 |
Paula Volpe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12871 Sw 135th Ter, Miami, FL 33186 Phone: 305-298-1432 Fax: 305-233-9156 |
Daylin Tapanes, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 621 Nw 58th Ct, Miami, FL 33126 Phone: 786-351-9770 |
Mrs. Alyssa Castro, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10401 Sw 50th Ter, Miami, FL 33165 Phone: 305-815-1850 |
Animari Colon Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10300 Sw 72nd St Ste 425, Miami, FL 33173 Phone: 787-423-7072 |
Vanessa Tablada Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1701 W Flagler St, Miami, FL 33135 Phone: 305-392-0883 |
 Marcel Alexander Arzola Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13014 Sw 85th Avenue Rd, Miami, FL 33156 Phone: 305-323-2364 |
News Archive
Modified NAGA: New enzyme for enzyme replacement therapy
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
Novel strategy provides new hope to fight COVID-19
A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled 'A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes' was published in Frontiers in Pharmacology, a leading peer-reviewed journal.
Interim data from Celator Pharmaceuticals' CPX-351 trial presented at the ASH meeting
Celator Pharmaceuticals today announced that interim safety and efficacy data from its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML) were presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, Louisiana (ASH Abstract # 1033).
Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide
New data on patient treatment satisfaction from the LEAD(TM) 6 trial presented on the 22nd October at the 20th World Diabetes Congress (International Diabetes Federation) shows that patients have higher overall treatment satisfaction with liraglutide than they do with exenatide.
Researchers use AI methods to 'redefine' Alzheimer's disease
As the search for successful Alzheimer's disease drugs remains elusive, experts believe that identifying biomarkers - early biological signs of the disease - could be key to solving the treatment conundrum.
› Verified 1 days ago
Speech-Language Pathologists
Physical Therapists
Occupational Therapists
Chiropractors
Optometrists
Podiatrists
Audiologists